Nicolas S.
- Country
- France
- Department
- Clinical Hematology and Cellular Therapy Department
Research Overview
- Phase 2 Study on Epcoritamab Monotherapy or Combined with Lenalidomide for Anthracycline-Ineligible Diffuse Large B-Cell Lymphoma Patients
- A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY, VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1)
- Efficacy and Safety Evaluation of Mosunetuzumab Plus Lenalidomide Versus Rituximab Plus Lenalidomide in Relapsed/Refractory Follicular Lymphoma
Data & Insights
Has run more than one trial at 77 of 238 partner sites.
Specializations
Lymphoma Research
The investigator specializes in treating various forms of B-cell lymphomas, with particular emphasis on diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma. Their research encompasses innovative therapeutic approaches using novel antibody-based treatments.
- B-cell lymphoma therapeutics
- Novel antibody combinations
- First-line treatment strategies
Their work extends to studying treatment responses in complex lymphoma cases.
Hematologic Transformations
A significant focus of the investigator's research involves Richter's syndrome, specifically studying the transformation of chronic lymphocytic leukemia into high-grade lymphoma. Their work examines innovative combination therapies for these challenging cases.
- Disease transformation patterns
- Combined therapeutic approaches
- Treatment response assessment
Their expertise includes evaluating novel treatment protocols for transformed lymphomas.
Therapeutic Innovation
The investigator explores bispecific antibody therapies and their combinations with established treatments. Their research includes evaluating immunomodulatory approaches and novel therapeutic combinations for both newly diagnosed and relapsed/refractory conditions.
- Antibody-based therapeutics
- Combination therapy strategies
- Treatment resistance mechanisms
They focus on developing effective treatment protocols for various lymphoma subtypes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.